Lung cancer in nonsmokers: Removal of drug may impact care
Experts warn that the withdrawal of mobocertinib, a drug used to treat a form of lung cancer that affects never-smokers, may leave patients in the United Kingdom in a precarious position.
Source: medicalnewstoday.com